DANIELLE ANDRUSKO: Open Payments
NPI 1285925313 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,927 in 70 payments from 16 companies in 2025. Trend: 2023 $695 · 2024 $1,775 · 2025 $1,927
Food & beverage: $1,917Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $612 |
| Janssen Biotech, Inc. | 8 | $258 |
| Madrigal Pharmaceuticals | 7 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $153 |
| Gilead Sciences, Inc. | 1 | $143 |
| GENZYME CORPORATION | 5 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| PFIZER INC. | 4 | $73 |
| QOL Medical, LLC | 3 | $58 |
| Lilly USA, LLC | 3 | $52 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, Epclusa, DUPIXENT, ENTYVIO, XIFAXAN, LINZESS.
Industry payments across NY — which companies pay providers there.
